Phagocyte function in juvenile periodontitis.

Study of neutrophils isolated from peripheral blood of patients suffering from aggressive periodontitis at the cellular level: Receptors and cytoskeletal reorganization. J Indian Soc Periodontol (2012) 0.79

Short-term exposure to oleandrin enhances responses to IL-8 by increasing cell surface IL-8 receptors. Br J Pharmacol (2014) 0.75

THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56

The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03

Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (1986) 5.68

Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest (1971) 3.58

Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest (1984) 2.57

Mediators of immunity: lymphokines and monokines. Adv Immunol (1980) 1.99

The case for periodontosis as a clinical entity. J Periodontol (1971) 1.73

Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70

Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature (1977) 1.59

Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun (1980) 1.48

Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol (1986) 1.45

Polyclonal B-cell activation: severe periodontal disease in young adults. Clin Immunol Immunopathol (1980) 1.38

Defective neutrophil chemotaxis in juvenile periodontitis. Infect Immun (1977) 1.36

Human neutrophil heterogeneity exists, but is it meaningful? Blood (1984) 1.35

Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme. J Immunol (1983) 1.33

Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe. J Immunol (1981) 1.33

Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21

Neutrophil chemotaxis in families with localized juvenile periodontitis. J Periodontal Res (1985) 1.18

Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16

Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Arthritis Rheum (1982) 1.12

1985 Kreshover lecture. Molecular factors influencing neutrophil defects in periodontal disease. J Dent Res (1986) 1.10

Neutrophil function and oral disease. J Oral Pathol (1985) 1.09

The polymorphonuclear leukocyte (PMNL) locomotor defect in juvenile periodontitis. Study of random migration, chemokinesis and chemotaxis. J Periodontol (1982) 1.04

Reduced chemotactic peptide binding in juvenile periodontitis: a model for neutrophil function. Biochem Biophys Res Commun (1981) 1.02

Association of an abnormality of neutrophil chemotaxis in human periodontal disease with a cell surface protein. Infect Immun (1987) 0.97

Abnormal leukocyte motility in patients with early-onset periodontitis. J Periodontal Res (1984) 0.95

Immunologic profile of juvenile periodontitis. II. Neutrophil chemotaxis, phagocytosis and spore germination. J Periodontol (1984) 0.93

Neutrophil function in localized juvenile periodontitis. Phagocytosis, superoxide production and specific granule release. J Periodontol (1986) 0.92

Clinical and laboratory studies of a family with a high prevalence of juvenile periodontitis. J Periodontol (1985) 0.89

Regulation of human leukocyte function by lipoxygenase products of arachidonic acid. Contemp Top Immunobiol (1984) 0.89

Juvenile periodontitis as a model for neutrophil function: reduced binding of the complement chemotactic fragment, C5a. J Dent Res (1983) 0.86

Altered free cytosolic calcium changes and neutrophil chemotaxis in patients with juvenile periodontitis. J Periodontal Res (1989) 0.86

Aberrant phagocyte function in Shwachman syndrome. Clin Exp Immunol (1987) 0.85

Leucocyte motility in the newborn: determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis. Clin Exp Immunol (1980) 0.84

Increased luminol enhanced chemiluminescence from peripheral granulocytes in juvenile periodontitis. Scand J Dent Res (1984) 0.84

Altered neutrophil migration during bacterial infection associated with a serum modulator of cellular motility. J Infect Dis (1979) 0.84

Effects of prostaglandin on the antigen- and mitogen-driven responses of peripheral blood lymphocytes from patients with adult and juvenile periodontitis. Clin Immunol Immunopathol (1978) 0.82

Chemotactic response of neutrophil polymorphonuclear leukocytes in juvenile periodontitis measured by the Leading Front method. Scand J Dent Res (1988) 0.78

Neutrophil chemotaxis and phagocytosis in juvenile periodontitis. J Periodontal Res (1984) 0.78

Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors. J Immunol Methods (1981) 0.77

Neutrophil chemotaxis and periodontal health relationships of young adult people in Thailand. Arch Oral Biol (1984) 0.77

Neutrophil chemotactic behaviour in patients with early-onset forms of periodontitis (I). Leading front analysis in Boyden chambers. J Clin Periodontol (1989) 0.76

Neutrophil chemotactic behaviour in patients with early-onset forms of periodontitis (II). Assessment using the under agarose technique. J Clin Periodontol (1989) 0.76

Effect of periodontal therapy on spontaneous lymphocyte response and neutrophil chemotaxis in localized and generalized juvenile periodontitis patients. J Clin Periodontol (1985) 0.76

Chemotaxis and surface glycoproteins of neutrophil granulocytes from patients with juvenile periodontitis. Arch Oral Biol (1984) 0.76

Comparison of two methods for measurement of chemotaxis of neutrophil polymorphonuclear leukocytes in vitro. Acta Pathol Microbiol Immunol Scand C (1987) 0.76

Abnormalities of leukocyte chemotaxis in patients with various forms of periodontitis. J Periodontal Res (1985) 0.76

Impaired polymorphonuclear leukocyte 15-lipoxygenase activity in juvenile and rapidly progressive periodontitis. Prostaglandins Leukot Essent Fatty Acids (1988) 0.76

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78

Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol (2001) 4.61

ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31

Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ (2007) 3.50

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44

Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res (2001) 3.38

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol (2001) 3.05

Induction of a basement membrane glycoprotein in embryonic kidney: possible role of laminin in morphogenesis. Proc Natl Acad Sci U S A (1980) 2.74

Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol (2001) 2.68

Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ (2005) 2.29

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16

Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci U S A (2000) 2.10

Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10

Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis (1998) 2.09

Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 2.03

Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis (1992) 1.86

The accident at Chernobyl and outcome of pregnancy in Finland. BMJ (1989) 1.81

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis (2004) 1.76

Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis (2004) 1.58

Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis (2005) 1.54

Changes in the glycosylation pattern during embryonic development of mouse kidney as revealed with lectin conjugates. J Histochem Cytochem (1987) 1.53

Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol Int (2001) 1.53

Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol (1994) 1.52

Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest (1995) 1.49

Prospective versus retrospective approach in the search for environmental causes of malformations. Am J Public Health Nations Health (1967) 1.47

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44

Differentiation of kidney mesenchyme in an experimental model system. Adv Morphog (1968) 1.44

Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci (2000) 1.44

Juvenile chronic arthritis in adult life: a study of long-term outcome in patients with juvenile chronic arthritis or adult rheumatoid arthritis. Clin Rheumatol (1999) 1.43

Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors. J Infect (2013) 1.43

Triggering of apoptosis by cathepsins. Cell Death Differ (2001) 1.39

Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) (2002) 1.38

Transferrin as a fetal growth factor: acquisition of responsiveness related to embryonic induction. Proc Natl Acad Sci U S A (1983) 1.35

Activin disrupts epithelial branching morphogenesis in developing glandular organs of the mouse. Mech Dev (1995) 1.35

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34

Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci U S A (1997) 1.32

Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res (1999) 1.32

Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis (2002) 1.32

Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ (2005) 1.28

Possible teratogenicity of imipramine-chloropyramine. Lancet (1973) 1.26

Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol (1989) 1.23

Defects of the central nervous system in Finland: I. Variations in time and space, sex distribution, and parental age. Br J Prev Soc Med (1977) 1.23

A matched-pair register for studies of selected congenital defects. Am J Epidemiol (1974) 1.22

Shift in collagen type as an early response to induction of the metanephric mesenchyme. J Cell Biol (1981) 1.22

Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett (1996) 1.21

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol (2004) 1.21

The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab. Clin Exp Rheumatol (2011) 1.19

Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19

Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19

The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J Virol (1997) 1.19

Reactive arthritis. Clin Rheum Dis (1985) 1.18

Induction of meiosis in fetal mouse testis in vitro. Dev Biol (1976) 1.18

Risk indicators in childhood malignancies. Int J Cancer (1975) 1.18

Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18

Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum (1996) 1.17

Clinical, radiographic and MRI findings of the temporomandibular joint in patients with different rheumatic diseases. Int J Oral Maxillofac Surg (2006) 1.17

Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis (2002) 1.14

Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog (1990) 1.13

Influenza epidemic and congenital defects. Lancet (1971) 1.11

Transfilter induction of kidney tubules as a function of the extent and duration of intercellular contacts. J Embryol Exp Morphol (1978) 1.10

Cancer-associated lysosomal changes: friends or foes? Oncogene (2012) 1.10

In vitro segregation of the metanephric nephron. Dev Biol (1981) 1.09

Transfilter induction of kidney tubles: correlation with cytoplasmic penetration into nucleopore filters. J Embryol Exp Morphol (1974) 1.09

Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum (2000) 1.09

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Ann Rheum Dis (2009) 1.09

Favourable social functioning and health related quality of life of patients with JIA in early adulthood. Ann Rheum Dis (2005) 1.09

Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol (1997) 1.08

Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) (1999) 1.08

Interferon response of human leukocytes during intrauterine and postnatal life. J Immunol (1968) 1.07

Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis (2004) 1.07

Recovery of A. actinomycetemcomitans from teeth, tongue, and saliva. J Periodontol (1991) 1.07

Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis (2001) 1.07

Differential regulation of two sets of mesonephric tubules by WT-1. Development (1997) 1.06

Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. Br Med J (Clin Res Ed) (1988) 1.06

Cell-mediated immune response in the diseased joints in patients with reactive arthritis. Scand J Immunol (1986) 1.06

Differentiation and vascularization of the metanephric kidney grafted on the chorioallantoic membrane. Dev Biol (1983) 1.06

JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ (2004) 1.06

[Antibiotic treatment in rheumatoid arthritis?]. Duodecim (1995) 1.06

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J (1997) 1.05

The effect of glove powders and their constituents on adhesion and granuloma formation in the abdominal cavity of the rabbit. Acta Chir Scand (1966) 1.05

The origin of the glomerular endothelium. Cell Differ (1982) 1.04

The time of appearance and distribution of sulphoglycoprotein antigens in the human foetal alimentary canal. Int J Cancer (1968) 1.03

Transient expression of syndecan in mesenchymal cell aggregates of the embryonic kidney. Dev Biol (1992) 1.02

Heredity of juvenile periodontitis. J Clin Periodontol (1980) 1.02

Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum (1991) 1.02

Familial protein intolerance with deficient transport of basic amino acids. An analysis of 10 patients. Acta Paediatr Scand (1967) 1.02

Foreign material and postoperative adhesions. N Engl J Med (1968) 1.01

Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene (2001) 1.00

The Finnish register of congenital malformations. Acta Univ Carol Med Monogr (1973) 0.99

Salmonella-specific antibodies in reactive arthritis. J Infect Dis (1991) 0.99

BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells. Biochem Biophys Res Commun (2001) 0.98

Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. Br J Rheumatol (1994) 0.98

Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis (2001) 0.98

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis. Clin Exp Rheumatol (2010) 0.98